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Abstract 
Lisa M. Charlton:  Protein behavior in crowded environments 
(Under the direction of Professor Gary J. Pielak, Ph.D.) 
 
The cell’s interior is a complex milieu where proteins exist in an environment 
crowded with other macromolecules.  The influence of macromolecular crowding is 
prevalent in every cellular function—from metabolism to signal transduction to 
protein folding.  It is even hypothesized that macromolecular crowding dictates the 
organization of the intracellular environment and the evolution of a single-cell 
species.  Even though proteins are prevalent in every biochemical process, we lack 
fundamental knowledge about how crowding affects proteins.  When studying 
proteins in a crowded environment, one can either develop a system that mimics the 
cellular interior or develop a technique that observes proteins inside cells.  Herein, I 
report a residue-level interrogation on the stability of chymotrypsin inhibitor 2 under 
macromolecular crowded conditions.  This is the first study that offers 
comprehensive information about the effects of crowding on the stability of the native 
state of a globular protein.  I also present observations about the behavior of 
globular, partially-folded, and natively-disordered proteins inside living E. coli and the 
consequences for in-cell NMR.  Lastly, I discuss our progress in transitioning from 
in-cell NMR for living E. coli to the yeast, Pichia pastoris.   
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 1 Introduction  
1.1 Macromolecular crowding and the cell  
As early as the late 1950s, science was interested in studying proteins and 
polysaccharides in concentrated systems (1).  At that time, a highly characterized 
polysaccharide, hyaluronan, was shown to have an unexpected concentration 
dependent sedimentation rate.  At infinite dilution the sedimentation coefficient 
depended on the molecular weight, but at higher concentrations, there was no 
molecular weight dependence.  This behavior was also observed for other polymers 
(1).  It was determined that hyaluronan formed a 3-dimensional, randomly-distributed 
chain network at high concentrations (>100 mg/ml) but behaved as a non-
interacting, expanded, random coil in dilute solution (1).  
The ability of hyaluronan to form a mesh-like network at high concentrations 
prompted further studies.  Ogston and Phelps, in 1960, made equilibrium 
measurements of the partitioning of proteins between hyaluronan solution and buffer 
and observed that proteins favored the buffer. From this observation, they concluded 
that hyaluronan excluded proteins and solutes from part of the space, and this 
excluded volume increased with increasing hyaluronan concentration (1, 2).  Not 
only was this phenomenon observed with other components, such as collagen and 
polyethylene glycol, but the results also agreed with theoretically calculated values 
2 
(1, 3, 4).  These results were some of the earliest demonstrations of excluded 
volume theory. 
Excluded volume theory states that two molecules cannot occupy the same 
space at the same time.   Therefore, the presence of cosolutes, particularly in high 
concentrations, excludes volume to another solute molecule. In general, a cell’s 
interior is 20-30% volume-occupied, thus, having 20-30% of its volume excluded to 
other molecules.  These macromolecules have partial specific volumes close to 1 ml 
mg-1, resulting in a crowded interior with macromolecules achieving concentrations 
of 200-300 mg/ml (5).  The steric exclusion that results from macromolecular 
crowding has considerable consequences for a cell’s function.       
The high protein concentration in the cellular environment affects diffusion of 
both small and large molecules; however, the cell has evolved to overcome these 
diffusive barriers.  With respect to metabolism, enzymes organize to form static, 
multi-enzyme complexes of related enzymes that co-localize with the respective 
small molecules (6).  The formation of such complexes promotes metabolite 
channeling, the direct transfer of a small molecule from one enzyme to an adjacent 
enzyme without the need for aqueous phase diffusion (7, 8).  This process helps 
metabolism proceed efficiently and overcome diffusive barriers.  Macromolecular 
crowding is also a force for protein association (9). It plays a role in the formation of 
the multi-enzyme complexes.  Westerhoff and colleagues showed that crowding 
reduces dissociation constants of enzyme complexes (10, 11), and Srere et al. 
linked high macromolecular concentrations to the organization of the cytoplasm into 
microenvironments for substrate channeling (8, 11).  When considering both 
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conclusions, one may argue that macromolecular crowding promotes metabolite 
channeling, which is considered to be an important evolutionary driving force behind 
cellular function (11).   
The mechanism by which macromolecules form discrete compartments in the 
nucleus can also be explained by macromolecular crowding.  The concentration of 
macromolecules in the nucleus approximates 100 mg/mL (12).  Within this 
environment, non-membrane bound, nuclear compartments, such as the nucleoli, 
form from the compartmentalization of their macromolecular components. 
Macromolecular crowding plays an essential role in the assembly and function of this 
compartment.   For instance, nucleoli disassembled and nucleolar transcription 
decreased by 85% when nuclei isolated from human erythroleukemia (K562) cells 
were expanded in medium of low cation concentration.  The macromolecular 
concentration decreased by approximately 2-fold upon nuclear expansion.  After 
addition of inert, penetrating macromolecules (8 kDa polyethylene glycol or 10.5 kDa 
dextran) to a homeostatic concentration, the nucleoli reassembled and nucleolar 
transcription resumed (12).  DNA replication in the nucleus also depends on a 
crowded environment.  A nucleus must form for DNA replication to initiate and 
progress (13) and has been demonstrated in vitro that crowding is critical to 
assembly of replication machinery (14).   
The influence of macromolecular crowding is prevalent in every cellular 
function—from metabolism to signal transduction to protein folding.  It is even 
hypothesized that macromolecular crowding dictates the organization of the 
intracellular environment and the evolution of a single-cell species (11).  The earliest 
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studies mimicked the cellular environment by crowding with inert macromolecules.  
These experiments are inherently flawed because the concentration of 
macromolecules inside cells is neither homogenous nor inert.  Experiments evolved 
to look at small molecules inside living cells, providing extraordinary detail on the 
function of the metabolome (15).  Now, the interest lies in monitoring the behavior of 
macromolecules inside living cells.  This can be accomplished using a novel 
technique, in-cell NMR.   
 
1.2 In-cell NMR 
In-cell protein NMR is the first technique to give atomic-level resolution inside 
living cells. An in-cell NMR spectrum can be collected on a 15N,13C, or 19F-enriched, 
overexpressed, soluble protein within the cell’s interior (16).  The first in-cell 
experiment on a protein was from the Brindle lab in 1997 (17).  These investigations 
quantified the rotational mobility of three glycolytic enzymes in Saccharomyces 
cerevisiae by observing an unnaturally incorporated 5-fluorotryptophan.  Four years 
passed before the technique was adapted by Serber et al. to heteronuclear single 
quantum correlation (HSQC) experiments, which detects 15N with a bound proton 
(18).  Serber’s paper showed proof of concept.  With the advent of this technique, 
not only could one begin to answer the important question—what is the behavior of 
macromolecules inside living cells?—but also could provide an answer with atomic-
level resolution.  Only a few groups, however, have attempted to incorporate this 
technique into their research.     
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The Pielak lab published the first paper using in-cell NMR to investigate a 
natively-disordered protein, FlgM (19).  A 15N HSQC spectrum was collected for 
FlgM inside living E. coli, and crosspeaks belonging to the C-terminal residues 
disappeared, whereas those belonging to the N-terminal residues remained. The 
data suggest that the C-terminal portion becomes structured inside cells.  Exchange 
is occurring between a structured and unstructured C-terminal which leads to line-
broadening and disappearance of crosspeaks.  The Pielak lab then went on to study 
another natively-disordered protein, α-synuclein (α-SN) (20).  McNulty et al. 
determined that the E. coli periplasm prevented a temperature induced 
conformational change that occurs at 35 oC in dilute solution (20).  The crowded 
periplasm stabilized the disordered α-SN monomer.  These two studies emphasized 
the need to examine proteins in their natural environment, particularly since many 
disordered proteins are involved in neurodegenerative diseases.   
Hubbard et al. reported the first in-cell NMR results relating the structure of a 
regulatory protein to its interaction with a potential drug (21).  The regulatory protein, 
CheY, is involved in chemotaxis in bacteria and binds both Mg2+ and Ca2+.  By 
comparing chemical shifts between spectra acquired in dilute solution and inside 
cells, Hubbard and colleagues concluded that CheY exists predominantly in the 
Mg2+-bound conformation inside cells.  They identified the residues that interact with 
the potential drug inside cells by observing chemical shift changes.   
The Shekhtman group provided the first glimpse of protein-protein 
interactions from studies of ubiquitin and signal transducing adaptor molecule 
(STAM2) inside E. coli (22). This study resulted in residue-specific information about 
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the binding interface between STAM2 and ubiquitin, and the authors hypothesized 
an increase in binding affinity supported by the appearance of an additional binding 
interface inside cells.  Shekhtman and colleagues observed chemical shift changes, 
line-broadening, and crosspeaks disappearing in regions of binding inside cells 
when compared to data obtained in dilute solution. 
The Dötsch lab was the first to move away from detecting 15N nuclei to 
observing 13C inside E. coli (23, 24).  Their 2003 paper incorporated 15N/13C 
enriched histidine in the protein NmerA to measure the intracellular pH and the 
tautomeric state of the histidine by observing the chemical shift of histidine  13Cε1 or 
13Cδ2 resonances (24). Their second paper in this area described a method for the 
selective observation of 13C-enriched methyl groups of methionine and alanine 
residues in proteins (23).  This method not only increases the sensitivity 3-fold 
compared to the observation of amide proton resonances but also provides an 
attractive alternative to monitoring large proteins and complexes intracellularly.   
   Over the span of one decade, in-cell NMR has been used to observe 
structural changes in individual proteins, protein-ligand interactions, and protein-
protein interactions inside living E. coli.  The next frontier is to develop in-cell NMR 
for proteins in eukaryotic cells.  
The first description of an in-cell experiment on a eukaryotic cell can once 
again be attributed to the Brindle lab who used S. cervesiae (17).  The Wagner lab, 
however, is credited with collecting the first 15N-HSQC spectrum inside a higher 
eukaryotic cell, namely Xenopus laevis oocytes (25).  Instead of endogenously 
expressing the protein and incorporating an NMR active nuclei, the Wagner lab 
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microinjected the purified, recombinant, 15N-enriched GB1 domain protein from E. 
coli into the cytoplasm of frog oocytes.  Microinjecting proteins into the cellular 
environment prevents nonspecific incorporation of NMR-active nuclei into 
background metabolites.  This elimination of background signal permits collection of 
high resolution NMR data at low intracellular protein concentrations (~10 µM) (26). 
The limitations of using this technique are then only size and solubility of the protein.   
Few groups have attempted to use in-cell NMR to monitor basic biophysical 
characteristics of a protein such as stability, dynamics, and diffusion.  I focused on 
protein stability.  There were two questions I attempted to answer with my research.  
Does the intracellular environment of E. coli stabilize the protein chymotrypsin 
inhibitor 2 as predicted by others? And does this stability correlate with the stability 
measured in the presence of macromolecular crowding agents?  Chapter 2 presents 
the results of measuring the stability of variant chymotrypsin inhibitor 2 in 300 g/L 
polyvinyl pyrrolidone (PVP) using NMR-detected amide proton exchange.  Chapter 3 
addresses several problems we encountered with in-cell NMR as well as the 
development of an encapsulation method as a solution to these problems.  Chapter 
4 reports the progress in developing in-cell NMR for monitoring proteins in the yeast 
Pichia pastoris.
  
 
 
 
 
 
2 Measuring the stability of chymotrypsin inhibitor 2  
 under macromolecular crowded conditions  
2.1 Introduction 
2.1.1 Implications of a crowded environment 
Macromolecular crowding is predicted to stabilize proteins (27).  Even though 
proteins participate in every biochemical process and are used as therapeutics, we 
lack fundamental knowledge about crowding and protein stability.  The consequences 
of macromolecular crowding are expected to be profound (27), yet, surprisingly, most 
biophysical studies are conducted only in dilute solution.  Quantitative information 
about the effects of crowding on globular proteins would not only provide new insights 
into intracellular constraints on protein stability, but also help find formulations that 
increase the stability and facilitate the long-term storage of protein pharmaceuticals.   
  As protein function in the cell occurs at macromolecular concentrations of 300 
g/L or greater (28), relevant experiments must attempt to mimic this environment.  
Sequestering a protein in a biocompatible, protein-like polymer provides a simplified 
representation of the cellular interior that focuses on the potential stabilizing effect of 
steric repulsion (29, 30).  A study conducted by Minton and coworkers showed that 
crowding with dextran (mw 35,000 Da) increases the equilibrium constant for folding of 
the molten-globule state of cytochrome c by 100-fold at pH 2.0 (30).  This observation 
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shows crowding can promote stabilization.  These data, however, were acquired 
under extreme conditions, did not involve the native state of the protein, and focused 
on bulk rather than residue-specific measurements.   
  Other studies of protein stability in the presence of macromolecules have 
reported minimal increases in stability (31-34).  These reports may underestimate the 
increase in stability because such systems often ignore aggregation and do not focus 
on stable native states (29, 35).  We have developed a simple system that provides 
information about the effects of macromolecular crowding on protein stability.  Our 
system gives unambiguous data about the effects of a polymeric crowding agent on 
the stability of each residue in a globular protein. This quantitative information offers 
new insights into macromolecular stabilization of proteins.  
 
2.1.2 Chymotrypsin inhibitor 2 
We chose chymotrypsin inhibitor 2 (CI2) as our model globular protein 
because this protease inhibitor is small (7.5 kDa), amenable to biophysical study, 
and well-studied in terms of its structure, folding, and stability (36-38).  More 
specifically, we used the I29A:I37H variant because the destabilizing isoleucine-to-
alanine change (39) allows stability measurements to be completed in 24 h, and the 
histidine side chain provides an internal pH probe.  We chose 40 kDa 
polyvinyl(pyrrolidone) (PVP40) as the macromolecular crowding agent because this 
random-coil polymer is extremely soluble, has protein-like solution properties, and is 
metabolically inert (40, 41).  PVP has been widely used in pharmaceutical 
applications (42, 43), and it retards both protein aggregation and proteolytic 
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degradation (44-46), but it’s usefulness as a stabilizing agent for small proteins has 
never been investigated.     
 
2.2 Materials and Methods 
2.2.1 Purification of chymotrypsin inhibitor 2 
The pet28a plasmid (Novagen) containing the gene for truncated wildtype CI2 
was a gift from Dr. Andrew Lee (UNC).  The first 19 residues of full length CI2 are 
disordered and are not included in this construct.  Residue 20 of full-length CI2 is 
referred to here as residue 1.  Site-directed mutagenesis was used to incorporate 
the I29A and I37H mutations (Stratagene kit).  The forward primer for I29A was 
5’GAA GCG CAG GCA ATC GTG C 3’, where the changed codon is bolded.  The 
forward primer for I37H was 5’ CT GCC GGT GGG CAC CCA TGT GAC CAT GGA 
ATA TC 3’.  The mutated plasmid was transformed into DH5α E. coli cells.  DNA 
sequence analysis (Genome Analysis Facility, UNC) with the T7 forward sequencing 
primer was used to confirm the sequence. 
After sequence analysis, the plasmid was transformed into BL-21(DE3-Gold) 
competent Escherichia coli cells (Stratagene).  The transformants were spread onto 
Luria broth agar plates containing 60 µg/mL kanamycin (LBkan).  Twenty-five mL of 
15N-enriched Spectra 9 media (Spectra Stable Isotopes) were inoculated with a 
single colony and incubated overnight at 37 oC with shaking at 200 rpm.  This 
overnight culture was diluted into 1 L of 15N-enriched Spectra 9 media in a 6 L 
autoclaved flask.  The culture was grown at 37 oC with shaking at 200 rpm to an 
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absorbance at 600 nm of 1.0.  The cells were induced with isopropyl β-D-1-
thiogalactopyranoside (Sigma) at a final concentration of 1 mM.  The cells were 
harvested after 5 h by centrifugation at 7300 x g in a swinging bucket centrifuge for 
20 min. 
The cell pellet was resuspended in 25 mL of 50-mM Tris buffer, pH 8.0.  The 
slurry was sonicated (Fisher Scientific, Sonic Dismembrator Model 500) on ice (4 
cycles, 4 min each, 30% duty cycle).  The lysate was centrifuged at 20,000 x g for 30 
min.  The pellet was discarded, and the supernatant treated with a 10% solution of 
polyethyleneimine (final concentration 0.2%).  After incubation on ice with stirring for 
30 min, the precipitated nucleic acids were removed by centrifugation at 20,000 x g 
for 30 min.  
The clear lysate was loaded onto an anion-exchange column (Q Sepharose® 
high performance resin, GE Healthcare, 1.6 cm x 10 cm) connected to an AKTA 
FPLC (GE Healthcare) at 4 oC.  The column was equilibrated with 25-mM Tris buffer, 
pH 8.0, before loading the sample.  After loading, the column was thoroughly 
washed with 100 mL of 25-mM Tris, pH 8.0.  CI2 does not interact strongly with the 
column material and was found in the flow-through and wash.  Purity was assessed 
by using SDS-PAGE on an 18% gel with Coomassie staining.  If needed, the protein 
was further purified in H2O by size-exclusion chromatography (HiLoad 16/60 
Superdex 75 column, 1.6 cm x 60 cm, GE Healthcare) at 4 oC.  The protein eluted 
between 80 and 100 mL.  Protein concentration was determined by using the 
absorbance at 280 nm and an extinction coefficient of 7.04 x 103 M-1cm-1 (47).  
Immediately following the purification, the protein was lyophilized and checked for 
12 
structural changes by comparing chemical shifts with nonlyophilized protein.  No 
significant change was observed.  Typical yield of pure protein is 100 mg per 1 L 
culture.   
 
2.2.2 Sample preparation for nonexchange experiments 
Lyophilized protein was resuspended in 1 mL of 50-mM sodium acetate buffer 
(90% H2O/ 10% D2O, v/v), pH 5.4, containing 50, 100, 200, or 300-g/L 40 kDa 
poly(vinylpyrrolidone) (PVP40, Fisher).  The final protein concentration was 800 µM.  
Consecutive, 1 h 15N HSQC spectra were collected at 37 oC.  The data were 
analyzed for changes in peak volumes, line-widths, and chemical shifts.   
 
2.2.3 NMR conditions for nonexchange experiments 
Two-dimensional, gradient-enhanced 15N HSQC spectra (48, 49) were 
acquired in dilute solution and in 300-g/L PVP40.  Lyophilized protein was dissolved 
in 50-mM sodium acetate buffer, pH 5.4 to a final concentration of 700 µM for dilute 
solution and in 50-mM sodium acetate, 300-g/L PVP40, pH 5.4 to a final 
concentration of 800 µM.  The data were collected on a Varian Inova 700-MHz 
spectrometer equipped with a coldprobe.  The 1H dimension was acquired with a 
sweep width of 11499 Hz and consisted of 1024 complex points.  The 15N dimension 
was acquired with a sweep width of 2188 Hz and consisted of 60 complex 
increments.  Twenty-four transients were collected for each spectrum.  The data 
were processed with NMRPipe and NMRDraw (50, 51).   
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1H and 15N resonance assignments were obtained from hncacb and 
cbca(co)nh spectra (52, 53) on a 1-mM sample of 13C-15N enriched protein (Table 1).   
2.2.4 NMR 
For exchange experiments, the spectrometer was first shimmed by using a 
protein sample in 50-mM sodium acetate buffer, pH 5.4, at 37 oC.  The exchange 
reaction mixture was prepared by dissolving lyophilized protein in 1 mL of 50-mM 
sodium acetate buffer, pH 5.4, to a final concentration of 700 µM, followed by 
centrifugation and transfer of the supernatant to a 5-mm NMR tube.  This buffer and 
those described below were made with 99.9% D2O (Acros Organics).  The sample 
was equilibrated in the spectrometer at 37 oC for 15 min before collecting the first 
spectrum.  Consecutive HSQC spectra were collected for 24 h.  The dilute-solution 
samples were saved for further experiments with GdmCl-induced denaturation.  For 
the crowding study, lyophilized protein was resuspended in 50-mM sodium acetate 
buffer, 300-g/L, 100-g/L, or 50-g/L PVP40, pH 5.4 to a final concentration of 800 µM.  
Shimming and data acquisition were performed as described above. The pH of each 
sample was checked before and after data collection using a Fisher brand pH meter 
and electrode.  The reported pH value for deuterated solutions is uncorrected for the 
isotope effect.  Peak volumes were obtained by using NMRview (51). 
 
2.2.5 Data analysis 
Exchange data were processed in SigmaPlot.  For the majority of residues, 
the decay in crosspeak volume versus time was fit to a three-parameter exponential 
decay: 
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   I = Aexp(-kobst) + C,                                  
where I represents the normalized peak volume, t is time in min, A is the amplitude 
of the exchange curve, kobs is the observed exchange rate determined from the 
decrease in signal versus time, and C is the constant taking into account the residual 
water.  Due to crosspeak overlap, residues 47/27, 8/11, 55/56 were fit a five-
parameter exponential decay  
             I = Aexp(-kobst) + B(-kobs2t) + C                             
The intrinsic rate constants for exchange, kex, were determined for each residue at 
the designated pH and temperature using the program Sphere (54).   
 
2.2.6 Measuring kex using CLEANEX-PM 
The intrinsic rate of exchange (kex) for amide protons in the unprotected loop 
of the I29A:I37H variant was measured by using the water saturation transfer 
experiment, CLEANEX-PM (55). Samples were prepared to a final concentration of 
800-µM protein in 50-mM sodium acetate buffer, pH 5.4 alone or in the presence of 
300-g/L PVP40, or 100-g/L N-ethylpyrrolidone (NEP).  The pH of each sample was 
determined before and after data collection using a pH meter.  The data were 
collected on a Varian Inova 600-MHz spectrometer at 37 oC.  The mixing times were 
0, 10, 20, 40 and 53 ms for dilute solution, 0, 10, 19, 25, and 53 ms for PVP40, and 
0, 10, 19, 25, and 35 ms for NEP.  NMR data were processed with NMRPipe (50) 
and analyzed with NMRview (51).  Data were fit as described by Hwang et al. (55) 
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2.2.7 GdmCl equilibrium denaturation 
Denaturation of the I29A:I37H variant of CI2 was measured by using circular 
dichroism (CD) spectrapolarimetry (Aviv Model 62DS) at 37 oC and 234 nm.  The 
NMR samples were diluted to 20 µM with 50-mM sodium acetate buffer made with 
D2O, pH 5.4.  One mL of the sample was transferred to a 1-cm pathlength quartz 
cuvette.  A solution of 20 µM protein in ~7 M GdmCl, 50-mM sodium acetate in D2O 
was automatically titrated into the sample.  The refractive index was measured at the 
end of each trial with a Palm Abbe refractometer (Misco).  The GdmCl concentration 
was determined by using the equation:(56)   
  [GdmCl] = [(n-1.3344)/0.0161] mol/L,                                      
where n is the refractive index.  
The CD signal was plotted versus GdmCl concentration and fitted to the 
following equation by using SigmaPlot (Systat Software): 
T*R/)C]GdmCl([*m
T*R/)C]GdmCl([*m
ddnn
m
m
e1
e)b]GdmCl[*m(b]GdmCl[*m][ −−
−−
+
+++=Θ , 
where [ Θ ] is the ellipticity at a particular [GdmCl], mn and bn are the slope and 
intercept of the native baseline, md and bd are the slope and intercept of the 
denatured baseline, Cm is the [GdmCl] at the transition midpoint, R*T is the product 
of the gas constant and absolute temperature. The free energy of denaturation 
'
denG
°∆ is calculated from: 
    'denG
°∆ = Cm * m,                                                          
where m is ∆ 'denG°∆ /∆[GdmCl].     
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2.2.8 Measuring the diffusion coefficient  
NMR experiments were performed on a 600-MHz Varian Inova spectrometer 
equipped with a triple resonance probehead and xyz gradients at 37 °C on a 1 mM 
sample of CI2 in 50-mM acetate buffer pH 5.4, 10% D2O.  An stimulated echo (STE) 
pulse sequence (57) with an x-gradient was employed to measure the diffusion of 
the small molecule reference compound, the sodium salt of trimethylsilyl-1-propane-
sulfonic acid (TSP).  The water signal was suppressed by using a selective pulse 
(sel-STE).  Convection was suppressed by application of an x-gradient (57).  The 
methyl proton signal of TSP was selectively excited in the diffusion measurements.  
Due to the short proton T1 (~30 ms) and T2 (~6 ms) values for CI2 in PVP40 (fast 
decay gave a low signal-to-noise ratio) a spin echo or stimulated echo was not 
suitable for assessing the diffusion of CI2 in PVP40.  A long 15N T1 (~ 1.4 s) was 
utilized to determine the diffusion of CI2 in PVP40 by a heteronuclear stimulated 
echo (X-STE) as described by Ferrage et al. (58).  Several pulse sequences were 
used to validate these measurements. [These pulse sequences included sel-STE 
(57), X-STE (58) and WIF-PGSTE (59).]   The measurements agreed within 5%. 
Ten 1D HSQC spectra were collected as a function of gradient strength.  The 
logarithm of the peak intensities were plotted versus gradient strength, and fitted to 
the following equation    
)3/(G)Iln()Iln( 222ot δ−∆δγ−= ,                      
where Io is the initial intensity, γ is the gyromagnetic constant, G and δ are the 
magnitude and duration of the field-gradient pulses, and ∆ is the delay between 
gradient pulses (57).  The slope of the line is the self-diffusion coefficient, D. 
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A 50 ms delay between gradient pulses was used for TSP, and 200 ms and 
800 ms were used for CI2 in buffer and PVP40, respectively. Gradient strengths 
ranged from 480 G/m to 5800 G/m.  The integrated area between 8 and10 ppm was 
used to monitor the signal decay as a function of gradient strength.  The intensities 
were normalized to the first experiment with weakest gradient strength.  Data were 
processed and analyzed by using VNMR (Varian) and NMRpipe.(50)  Origin lab 
software was used to fit the NMR diffusion data. 
 
2.3 Results and Discussion 
High concentrations of crowding agents might alter a globular protein’s 
structure and aggregation state (60), thereby confounding interpretation of their 
effects on stability.  NMR chemical shifts are sensitive, empirical indicators of 
structure.  We found PVP40-induced changes in 1H and 15N backbone chemical 
shifts only in the loop and turn regions of CI2 (Figure 2.1).  Small changes in loops 
and turns are expected because crowding causes compaction and, unlike the 
protein core, loops are not by definition maximally compact (61, 62).  These 
chemical shift changes might also reflect weak interactions between PVP and these 
surface regions.  We assessed the aggregation state of CI2 by quantifying the effect 
of PVP40 on the protein’s extinction coefficient, 1H and 15N resonance line-widths, 
and self-diffusion (Figures 2.2 and 2.3).  A chemical reaction, such as dimerization, 
should alter the protein’s molar extinction coefficient.  The extinction coefficient, 
however, does not change in the 300-g/L PVP40 solution over the 24 h required to 
conduct a stability measurement.   
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An increase in line-widths would signify an increase in the molecular weight of 
the protein, particularly aggregation.  Small increases and decreases in line-widths 
were observed in dilute solution and in 300-g/L PVP40 (Figure 2.2B).  Since the 
changes were both positive and negative, instead of solely positive, these changes 
are attributed to random error introduced during the experiment.    
 Lastly, the diffusion data are consistent with the monomeric nature of the 
protein in both dilute and crowded solutions.  The ratio of the self-diffusion coefficient 
(D) of CI2 in buffer to CI2 in 300-g/L PVP is 12; whereas, the ratio of D for the small 
molecule standard, trimethylsilyl-1-propane-sulfonic acid sodium salt (TSP), in buffer 
compared to 300-g/L PVP is 6 (Figure 2.3).  The ratio of these two values is the 
oligomeric state of CI2 in PVP, which suggests CI2 is a dimer.  Diffusion 
measurements are interpreted using the Stokes-Einstein equation which takes into 
consideration the viscosity of the solution.  By comparing DTSP to DCI2, one can 
eliminate the need to measure the viscosity of the solution.  However, TSP was 
determined to be an inappropriate standard for this experiment because of the large 
size difference between PVP40 and the small molecule.  Therefore, we can 
conclude that CI2 is no more than a dimer in 300-g/L PVP as measured by the self-
diffusion. 
 We conclude CI2 does not aggregate in the presence of 300-g/L PVP.  
These results indicate that the combination of PVP40 and CI2 is amenable to 
stability studies. 
We used amide-proton exchange to quantify stability.  In our experiments, the 
protein is lyophilized and then re-dissolved in a D2O-containing solution (buffer alone 
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or buffer plus PVP40).  The exchange rate of backbone amide protons for 
deuterons, kobs, is quantified by measuring the decrease in the signal from individual 
amide protons in serially-acquired NMR spectra over 24 h.  The exchange reaction 
is described by equation 1 (63). 
          exchangestates openclosed ex
opk
clk
k⎯→⎯⎯⎯ →⎯⎯⎯←                              (1) 
 The native state of the protein opens and closes with rate constants kop and 
kcl.  Exchange occurs in the solvent-exposed open state with the rate constant kex.  
The generally accepted view is that the open states are ensembles whose 
subpopulations range from small, low amplitude fluctuations of the native state to 
rare, globally unfolded forms (64, 65). 
As shown in Figure 2.4, the 300-g/L PVP40 solution exhibits considerably 
slower exchange compared to dilute solution.  This result is consistent with 
crowding-induced stabilization, but quantitative analysis of protein stability requires 
information about the rate constants in equation 1.   
The observed first-order rate constants for exchange at individual residues, 
kobs, can be used to assess stability provided kop/kcl << 1 and kcl >> kex.  Under these 
conditions,                            
   ex
'
opexclopobs kKk)k/k(k
°==                                               (2)                             
where 'opK
°  is the equilibrium constant for opening.(66)  Stability is measured as the 
free energy of opening, '°∆ opG , where                                                       
                    −=∆ °° 'op'op KlnRTG                                                    (3) 
and R is the gas constant and T is the absolute temperature.  We know that kop/kcl 
20 
<<1 for the slowly-exchanging protons because independent unfolding experiments 
give kop/kcl ~ 10-3 (Figure 2.5).  To show that kcl>>kex, we measured the pH 
dependence of kobs (66).  If kcl>>kex is true, then kobs is dependent on kex which is   
acid/base catalyzed (66).  Therefore, if kcl >> kex, plotting kobs values at one pH 
against values at another pH will give a line of unitary slope (36).  As anticipated, 
plots for experiments conducted in dilute solution and in 300-g/L PVP40 at two pH 
values (Figure 2.6) exhibit unitary slopes.  The data show that kop/kcl will equal Kop 
and can be used to assess stability in dilute solution and in 300-g/L PVP40, but using 
equations 2 and 3 to assess the effect of crowding requires knowledge of kex in dilute 
and crowded conditions. 
Values of kex in dilute solution are computed from data on unstructured 
peptides (54, 67, 68).  To assess the effect of 300-g/L PVP40 on kex, we used 
residue 37 in CI2’s unprotected, extended loop (residues 35-45) as a mimic for an 
unstructured peptide.  Exchange in the loop occurs too quickly to use the method 
described above, so we turned to the saturation transfer experiment, CLEANEX-PM 
(55).  Those data indicate that kex in 300-g/L PVP40 equals kex in dilute solution 
(Figure 2.7).  With these data in hand, we calculated '°∆ opG values at each residue of 
CI2 and assessed the effects of crowding on stability. 
A histogram of '°∆ opG values in dilute solution and 300-g/L PVP40 as a function 
of CI2 sequence position is shown in Figure 2.8 ,and '°∆ opG values are superimposed 
on the protein structure (PDB 2CI2) in Figures 2.9A and 2.9B.  PVP40 
increases '°∆ opG for all measurable residues with a maximum increase of ~3 kcal/mol, 
which corresponds to a 100-fold increase in the equilibrium constant for folding 
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(1/ 'opK
° ). This agrees with the predicted increases of 10- to 100-fold (27).  We 
attempted to confirm the maximum '°∆ opG  values by performing a circular-dichroism 
detected denaturation in PVP solutions supplemented with the denaturants 
guanidinium chloride or urea (Figure 2.10).  Unfortunately, PVP interacts strongly 
with the cosolutes.  Such behavior has been observed previously (41).  
Nevertheless, we feel our results are valid because the PVP concentration 
dependence of '°∆ opG values extrapolates smoothly to zero PVP concentration (vide 
infra), and many previous studies have shown correspondence between maximum 
'°∆ opG and free energies derived from global denaturation experiments (64).   
To show the increases in '°∆ opG arise from the macromolecular nature of the 
crowding agent, we repeated the experiment in a solution of a model monomer for 
PVP, N-ethylpyrrolidone (NEP).  CI2 precipitates in 300-g/L NEP, but is soluble in 
100-g/L NEP.  At this concentration, kex, as measured with the CLEANEX-PM 
experiment, increases four-fold compared to dilute solution (Figure 2.7).  We used 
this NEP-observed value to scale the calculated kex values.  Values of '°∆ opG in 100-
g/L NEP are overlaid on the protein structure in Figure 2.9D.  NEP has a small 
effect, with most changes being destabilizing compared to dilute solution.  Higher 
NEP concentrations are expected to be even more destabilizing.  These 
observations show that the stabilizing effect of PVP arises from its macromolecular 
nature and agrees with data showing that the effect of polyethylene glycol on the 
overall stability of lysozyme exceeds the effect of PEG’s monomer, ethylene glycol 
(69). 
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Measuring '°∆ opG on a residue-by-residue basis provides insight into the native 
and open states of CI2.  Since the magnitude of '°∆ opG in dilute solution depends on 
the amount of surface exposed upon unfolding (70), it is expected, and observed 
(Figure 2.9A), that the smallest '°∆ opG values tend to correspond to surface-exposed 
residues, and the largest values correlate with residues that become exposed only 
upon extensive unfolding.  Identical patterns of local and global unfolding are 
observed in PVP40 and NEP compared to dilute solution (Figures 2.9B and 2.9C).  
These data show that PVP40 significantly increases the stability of globally-unfolding 
residues compared to dilute solution and NEP while leaving the stability of locally-
unfolding residues nearly unchanged.  From these observations, we conclude that 
crowding with PVP40 does not alter the exchange-competent forms (i.e., the open 
states) but decreases their probability.   
Theories used to explain the effects of stabilizing (or destabilizing) cosolutes 
on protein stability predict that 'opG
°∆ should depend not only on differences in surface 
area but also on cosolute concentration (27, 70-72).  We expect a positive 
correlation between '°∆ opG values and the differential quantity, ∂ '°∆ opG /∂[PVP], which 
describes the sensitivity of '°∆ opG to PVP40 concentration.  To test this idea we 
examined the effect of PVP40 concentration on '°∆ opG and mapped values of 
∂ '°∆ opG /∂[PVP] onto the structure (Figure 2.9D).  Comparing Figure 2.9B to Figure 
2.9D shows exactly the correlation predicted by theory; residues with the 
largest '°∆ opG  values have the largest ∂ '°∆ opG /∂[PVP] values. 
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2.4 Conclusions 
We used a simple system comprising a globular protein, a random-coil 
polymer, and an established equilibrium thermodynamic method to quantify the 
stabilizing effects of macromolecular crowding at the level of individual residues.  
The maximum stabilizing effect is sizable, up to ~3 kcal/mol, which represents an 
increase in stability of ~50% compared to dilute solution. Our residue-by-residue 
measurements show that crowding has the largest effects on opening reactions that 
expose the most surface area but has little or no effect on regions that are solvent 
exposed in both the native and open states. This observation reinforces the 
assertion that macromolecular crowding stabilizes the native state by destabilizing 
the unfolded states. This observation also suggests that information about turns and 
unstructured loops gained under equilibrium conditions in dilute solution are valid 
under crowded conditions.  Furthermore, the significant increase in protein stability 
as a result of crowding with a biocompatible polymer could lead to new approaches 
in the design and storage of protein pharmaceuticals. 
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2.5 Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. Plots of chemical shift disturbances in 300 g/L PVP and 100 g/L 
NEP. 
Panel A: The average weighted chemical shift difference, with error bars 
representing the standard deviations from three trials, for the I29A:I37H variant of 
CI2 in 300 g/L PVP40 under exchange conditions.  Weighted chemical shift 
differences were calculated by using the formula [(∆1H ppm)2 + (∆15N ppm x 
0.154)2/2]1/2(73).  These data provide an estimate of the precision for measuring 
chemical shifts.  Panel B: The weighted chemical shift difference between HSQC 
spectra acquired in 300 g/L PVP40 and dilute solution.  Weighted differences greater 
than 0.02 ppm are considered significant.  Panel C:  The weighted chemical shift 
difference between HSQC spectra acquired 100 g/L NEP and dilute solution.
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Figure 2.2. Plots of absorbance at 280 nm and linewidth changes in 300 g/L 
PVP. 
Panel A: Dependence of the 280-nm absorbance on protein concentration in dilute 
solution, in 300 g/L PVP40, and in 400 g/L dextran at 0 and 24 h for the for the 
I29A:I37H variant of CI2.  The extinction coefficient is 7.4 ± 0.3 mM-1cm-1for dilute 
solution (▼), 7.4 ± 0.4 mM-1cm-1 for 300 g/L PVP40 at 0 h (●), 7.7 ± 0.6 mM-1cm-1 for 
300 g/L PVP40 at 24 h (o), and 3.3 ± 0.3 mM-1cm-1 for 400 g/L dextran (∇).  The 
dextran data show that this technique is sensitive to aggregation. The published 
coefficient for CI2 is 7.0 mM-1cm-1(47).  The similar values for dilute solution and 
PVP40 are consistent with the protein being a monomer in PVP40.  Panel B: The 
change in linewidths at half-height (ppm) for the 1H (white bars) and 15N (black bars) 
backbone amide resonances at 0 and 24 h in 300 g/L PVP40 under nonexchange 
conditions.  The observation of both small positive and small negative changes 
suggests the differences are not the result of protein aggregation.  Residues 55/56 
and 29/31 were not well enough resolved to determine linewidths. 
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Figure 2.3. Molecular diffusion of the I29A:I37H variant in dilute solution and in 
300 g/L PVP40, 50 mM acetate buffer, pH 5.4, 37 oC. 
Using trimethylsilyl-1-propane-sulfonic acid sodium salt (TSP) as a reference small 
molecule, the diffusion coefficient of CI2 was 2 times greater in 300 g/L PVP40 than 
dilute solution suggesting dimerization.  However, the measured diffusion of TSP in 
PVP40 results is an apparent diffusion coefficient ratio that is most likely an 
overestimation of the true value (74).  We can presume that CI2 is a monomer in 
crowded solution, but can conclusively state that it is no more than a dimer.   
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Figure 2.4.  Exchange curves for Leu 32 (●) and Asp 52 (▼) in dilute solution 
(blue) and 300 g/L PVP (green).  
PVP40 slows amide proton exchange.  Exchange curves for the amide protons of 
Leu 32 (●) and Asp 52 (▼) in dilute solution (green) and 300 g/L PVP40 (cyan).  
Conditions: 50 mM d3-acetate buffer, pH 5.4, 37 oC.   
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Figure 2.5. GdmCl denaturation curves of the I29A:I37H variant at 37 oC for 
three trials measured by circular dichroism at 234 nm. 
The sample was 20 µM protein in 50 mM acetate buffer made with D2O.  The 
average m value is 1.97 ± 0.04, the average [GdmCl]50% is 2.05 ± 0.04, and the 
average ∆Gden is 4.0 ± 0.2 kcal/mol.  
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Figure 2.6. Plot of log kobs (pH 5.4) vs. log kobs (pH 6.2) to determine EX2 
mechanism. 
The I29A:I37H variant exchanges according to the EX2 mechanism.  Linear 
regression yields slopes and R2 values of 0.91 ± 0.5 and 0.92 in dilute solution 
(green) and 1.10 ± 0.08 and 0.86 in 300 g/L PVP40 (cyan), respectively. The error 
bars represent the standard errors for the averages from three trials collected at pH 
5.4.   
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Figure 2.7. Exchange of Residue 37 using CLEANEX-PM 
The exchange of residue 37 was measured in 50 mM acetate, pH 5.4 at 37oC in 300 
g/L PVP40 (cyan), in dilute solution (green), and in100 g/L NEP (magenta) using the 
CLEANEX-PM experiment (55).  The rate is 9 ± 2 s-1 in dilute solution, 7 ± 1 s-1 in 
PVP40, and 32 ± 3 s-1 in NEP.  The smooth curve is determined as described by 
Hwang et al.(55)  Crowding with 300 g/L PVP40 does not change the rate of 
exchange for loop residue 37, which is essentially unprotected, but adding 100 g/L 
NEP increases the rate approximately 4-fold.  
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Figure 2.8. Histogram of  for chymotrypsin inhibitor 2 in 300 g/L PVP and dilute 
solution. 
Macromolecular crowding with PVP40 stabilizes the I29A:I37H variant of CI2 relative 
to dilute solution.  Values of '°∆ opG , in 300 g/L PVP40 (cyan) and dilute solution 
(green) are plotted versus residue number.  The height of each bar represents the 
average from three trials.  The error bars represent the standard deviation.  
Conditions: 700 - 800 µM variant protein, 50 mM acetate buffer made with D2O, pH 
5.4.  The inset shows the backbone structure of PVP. 
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Figure 2.9. Ribbon structure of wild-type chymotrypsin inhibitor 2 (PDB, 2CI2) 
colored by '°∆ opG .  
 (A) dilute solution (B) 300-g/L PVP40, and (C) 100-g/L NEP  [blue: '°∆ opG < 3.0 
kcal/mol; green: 3.0 kcal/mol < '°∆ opG  < 5.0 kcal/mol; yellow: 5.0 kcal/mol < '°∆ opG  < 
5.5 kcal/mol; cyan: 5.5 kcal/mol < '°∆ opG < 8.0 kcal/mol].  (D) '°∆ opG  was measured in 
0, 50, 100, and 300-g/L PVP40, and δ '°∆ opG / δ[PVP40] values were superimposed 
onto the structure [blue: δ '°∆ opG / δ[PVP40]  = 0, yellow: 0 < δ '°∆ opG / δ[PVP40]  < 2.5 x 
10-3 (kcal/mol)/M, cyan: 2.5 x 10-3 (kcal/mol)/M < δ '°∆ opG / δ[PVP40]  < 1.0 x 10-2 
(kcal/mol)/M].  Residues for which there are no data are colored grey. 
C 
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Figure 2.10. GdmCl denaturation of the I29A:I37H variant at 37 oC in 300 g/L 
PVP for three trials measured by circular dichroism at 242 nm.   
The sample was 800 µM in 50 mM acetate buffer made with D2O, 300 g/L PVP. The 
average m value is 2.3 ± 0.2 , the average [GuCl]50% is 1.31 ± 0.04, and the average 
∆Gden is 3.0 ± 0.3 kcal/mol.       
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Figure 2.11. Standard curve relating refractive index to [GdmCl] in 300 g/L 
PVP. 
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Table 2.1. 1H, 15N assignments and kex for the I29A:I37H variant of 
chymotrypsin inhibitor 2 
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3 Caveats of in-cell NMR in Escherichia coli 
3.1 Introduction to in-cell NMR of globular, partially folded, and 
natively disordered proteins 
In-cell NMR is quite advantageous for studying proteins in a near 
physiologically relevant environment, such as inside living E. coli.  The technique 
gives atomic-level information about a protein in a noninvasive manner.  The primary 
disadvantage, however, is that the technique depends tremendously on the 
characteristics of the protein.  In general, NMR is limited by the molecular weight of 
a protein.  A large protein will slowly tumble causing broadening of linewidths, which 
can lead to complete disappearance of usable data.  This tumbling rate depends 
upon the viscosity of the solution, and the viscosity of the E. coli cytoplasm is 9 times 
that of water (75).  The viscosity of other cells types is 2 times greater than that of 
water (76).  This increase in viscosity leads to an apparent increase in the molecular 
weight of a macromolecule inside the cytoplasm of all cell types, but most drastically 
for E. coli.   
For a globular protein, signals from the amide backbone depend on the 
tumbling rate; therefore, the protein must be small, not bound to other 
macromolecules, and soluble.  The relaxation of a natively-disordered protein, 
however, depends, not only on the overall tumbling, but also on rotation of the 
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backbone since it does not have a rigid structure.  The increased rotational freedom 
reduces T2 relaxation before severe line-broadening occurs.  This allows one to 
observe a greater molecular weight range for natively-disordered proteins inside the 
cell compared to globular or partially-folded proteins.  For instance, the Pielak lab 
has observed the natively disordered proteins FlgM (14 kDa) (19), α-SN (14 kDa) 
(20, 77), and human tau protein (45 kDa) [Brian McNulty, unpublished], and the 
Dötsch lab has observed the globular protein NMerA (7 kDa) (18).   
The most common application of in-cell NMR is the acquisition of a 15N HSQC 
spectrum on the protein of interest.  Incorporation of 15N into cellular components 
creates background signal.  Serber et al. have determined that the amount of 
background signal arising from incorporation of 15N into other cell constituents is 
independent of both media and induction protocol (16).  For instance, rifampicin was 
used to suppress synthesis of bacterial proteins; however, the background level was 
not altered by this addition (16).  Since incorporation of 15N in background molecules 
occurs with consistency, the expression level of the protein of interest is a relevant 
parameter when attempting to observe protein spectra inside cells. It is estimated 
that a protein must be overexpressed to greater than 5% of the total soluble protein 
inside living E. coli to be observed (16).  Other protein specific factors, such as 
protein-protein interactions and stability, will affect the spectrum, but none will have 
as great of an influence on the quality of the spectrum as the expression level and 
the correlation time.   
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3.2 Materials and Methods 
3.2.1 In-cell NMR preparation of chymotrypsin inhibitor 2 (CI2) and 
apocytochrome b5 
The following protocol is for in-cell NMR of CI2 and apocytochrome b5.  The 
plasmid was transformed into BL21 (DE3) Gold cells (Stratagene), plated on LB agar 
plates, and grown overnight at 37 oC.  A single colony was used to inoculate 20 mL 
15N-enriched Martek media (Spectra Stable Isotopes).  The culture was grown 
overnight at 37 oC with shaking (225 rpm).  Fifteen mL of this starter culture was 
added to 250 mL of media in a 1 L Erlenmeyer flask.  The culture was grown to an 
optical density of 1.0 (Abs600) at 37 oC with shaking (225 rpm).  The cells were 
induced with isopropyl thiogalactoside (IPTG, final concentration, 1 mM), and 
expression was allowed to occur at 37 oC for 5 h.  Chloroamphenicol was then 
added to a final concentration of 50 µg/mL, and the culture was shaken for another 
15 min.  The cells were harvested at 1600 g for 30 min.  The supernatant was 
decanted, and 2 mL were reserved for resuspension and spectrometer shimming.  
The wet pellet typically weighs 1.2 -1.5 g.  The variation arises from the liquid 
remaining in the pellet.  The pellet was resuspended in 200 µL of spent media (or 
buffer of interest).  The final volume of the sample was approximately 1.2 mL.  A 
90:10 mixture of cell slurry:D2O was added to the NMR tube.   
 The cell slurry was subjected to dilution plating before and after the NMR 
experiment to determine the fraction of cells that survived.  The cell pellet and 
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supernatant were subjected to analysis by SDS-PAGE to determine the relative 
amount of protein found in the supernatant.  
 
3.2.2 In-cell NMR preparation of α-synuclein and FlgM 
The preparation for in-cell NMR of α-SN and FlgM was adapted from McNulty 
et al. (20) and Dedmon et al. (19), respectively.  The pT7-7 vector containing the α-
SN gene was transformed into E. coli BL21 Gold cells and selected with ampicillin.  
The pMCA4 vector containing the FlgM gene was also transformed into BL21 cells 
and selected with ampicillin (100 µg/mL).  A 15 mL overnight culture was grown from 
a single colony and used to inoculate 250 mL of LBamp.  The culture was grown to an 
Abs600of 1.0 at 37 oC with shaking at 225 rpm.  The cells were gently centrifuged at 
1600 g for 30 min at 4 oC.  The cell pellet was resuspended in 250 mL of M9 minimal 
media (Table 2.1), induced with IPTG to a final concentration of 1 mM, and grown in 
a rotary shaker (225 rpm) at 37 oC for 4 h.  Following expression, the cells were 
harvested by centrifugation at 1600 g for 30 min at 4 oC.  The cell pellet was 
resuspended in spent media to a final volume of 1.5 mL.  A 90:10 mixture of 
sample:D20 was placed in a 5 mm NMR tube for data collection.   
 
3.2.3 NMR analysis of extracellular protein 
 The following method was used to determine the amount of protein NMR 
signal arising from the extracellular supernatant during an in-cell NMR experiment 
for CI2, apocytochrome b5, α-SN, and FlgM.  In-cell NMR samples were prepared in 
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duplicate (referred to as Sample 1 and Sample 2).  Sample 1 was immediately 
centrifuged.  The supernatant from sample 1 was reserved for an NMR experiment 
and for analysis by SDS-PAGE.   A 15N HSQC was collected on a cell slurry from 
sample 2 before the supernatant was harvested by centrifugation at 775 x g for 30 
min.  The supernatant was then removed and 15N HSQC spectra were collected on 
the supernatants from sample 1 and sample 2.  The peak intensities were used to 
quantify the extracellular signal using NMRview (51).   
 
3.2.4 Post-spectrometer SDS-PAGE analysis 
The volume of the post-spectrometer sample was determined to two 
significant figures. The volume was approximately 1.5 mL.  The sample was then 
centrifuged at 775 x g for 45 min, and the supernatant was removed.  Both the 
supernatant and the cells were again centrifuged at 16,000 x g for 30 min.  The 
second centrifugation frees the supernatant of cellular debris and removes most of 
the external buffer from the pelleted cells.  All supernatants were combined and 
referred to as the extracellular supernatant since this contains any protein that has 
leaked from the cells during the experiment.   
The volume of extracellular supernatant was subtracted from the total volume 
of sample to determine the volume of the cells.  The pellet was resuspended in a 
volume of lysis buffer (50-mM acetate, pH 5.5)1 that was equivalent to the pellet 
volume. Lysozyme was not used because it overlaps on SDS-PAGE with the 
                                            
1 The lysis buffer will differ per protein.  Use the lysis buffer that is in your purification. 
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proteins investigated.  The resuspended cells were subjected to ten freeze/thaw 
cycles by using a dry ice/ethanol bath and room temperature water bath.  The slurry 
was then centrifuged at 16,000  g for 30 min.  The supernatant was removed, and 
the pellet was centrifuged again for 15 min.  The two supernatants were combined, 
and referred to as the cellular supernatant.  Finally, the ratio of the combined 
supernatant volumes to the original volume of the pellet was determined.   
The extracellular supernatant volume was adjusted according to the increase 
in volume in the previous step.  For instance, if the original pellet volume is 600 µL 
and the supernatant volume from the pellet is 700 µL, the volume of the extracellular 
supernatant is increased by 15% with the lysis buffer.   
 Ten µL of extracellular supernatant was diluted to 40 µL with lysis buffer, and 
8 µL of SDS loading dye.  This regimen was repeated with the cellular supernatant.  
The samples were then placed at 90 oC for 5 min.  Three µL of each sample were 
loaded into an 18% SDS gel (75 mm x 8 cm).  Gels were electrophoresed at 200 V 
for 50 min.  The gel was stained with Coomassie Brilliant Blue and destained.  The 
destained gel was scanned and analyzed using the freeware program ImageJ (NIH, 
http://rsb.info.nih.gov/ij/).  The pixel density from the extracellular and cellular 
supernatants was compared directly to quantify the relative amount of protein that is 
in the extracellular supernatant.   
 
3.2.5 Encapsulating E. coli cells 
A solution of 2% w/v alginate (Sigma) was prepared by dissolving solid 
alginate in LB.  The solution was heated until all the alginate dissolved and then 
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filtered with a 0.22 filter.  E. coli cells expressing 15N-enriched protein were grown 
and prepared as previously described for in-cell experiments.  A 50% v/v solution 
was made from the 2% alginate stock solution and the cell slurry.   
The electrostatic encapsulation device comprised a 1-mL syringe, a 24-gauge 
angiocatheter (24 gauge, 0.7 x 19 mm tip, winged, Braun), a 23-gauge needle, a 
syringe pump, and an adjustable power supply ranging between 3.2 and 5.5 kV. The 
cell slurry/alginate mixture was loaded into the 1 mL syringe, the angiocatheter was 
attached, and the syringe was connected to the syringe pump in a vertical position 
(Fig. 3.1). The needle was inserted through the angiocatheter in a horizontal 
orientation. A 250-mL beaker with a stir bar and 150 mL of 150-mM CaCl2 was 
placed below the syringe as a receiving bath.  The positive voltage clamp was 
connected to the needle, and a copper-tip grounding wire was submerged in the 
receiving bath.  The power supply was set to 3.7 kV, and the syringe pump was set 
to a rate of 0.71 mL/min.  The cell slurry/alginate mixture was forced through the tip 
of the angiocatheter and streamed into the receiving bath below.  The Ca2+-ion 
induced polymerization of the alginate formin the encapsulated bead of cells.  The 
encapsulated cells were retrieved with suction and placed in solution of 90:10 
LB/D2O for NMR studies.   
 
3.2.6 NMR experiments of encapsulated cells  
Data were collected on encapsulated cells expressing α-SN and CI2 for 16 h.  
The 15N HSQC spectra consisted of 128 transients and 100 increments.  Following 
the data collection, the LB/D2O solution was removed from the encapsulated E. coli 
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cells and replaced with 1 mL of 10 mM ethylenediaminetetraacetic acid (EDTA).  
The EDTA dissolves the polymer by binding Ca2+.  An 15N HSQC spectrum was 
collected on the unencapsulated cells.   
 
3.3 Results 
3.3.1 In-cell NMR of chymotrypsin inhibitor 2 
It was initially believed that the CI2 was the perfect molecule for in-cell NMR.  
The protein is small, soluble, and overexpressed.   Initial experiments resulted in 
well-resolved, low noise HSQC spectra of CI2 as seen in Fig. 3.2.  The sample was 
analyzed for extracellular protein by SDS-PAGE, and this amount was determined to 
be minimal, ~100 µM (Fig. 3.3).  However, the initial conclusions were incorrect.  
Although the amount of extracellular protein was small relative to the amounts of 
cytoplasmic protein (Fig 3.3), the NMR signal detected was from the extracellular 
protein.  Figure 3.2, panel A shows a spectrum of the supernatant that has been 
immediately harvested from cells expressing CI2; panel B is a spectrum of CI2 
“inside cells”; and panel C is a spectrum of supernatant that has been harvested 
after an in-cell experiment.  It was initially thought that signal from inside the cells 
was seen “on top” of the signal from the extracellular protein since the concentration 
of cytoplasmic protein was at least 10-fold higher.        
When consecutive HSQC spectra were collected on E. coli cells expressing 
CI2, an increase in both peak intensity and volume occured with time.  An increase 
in peak volume indicates an increase in protein concentration; whereas, an increase 
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in peak intensity can be either the result of a decrease in linewidth, caused by, for 
instance, a decrease in viscosity, or an increase in protein concentration. A 
decrease in viscosity would be expected if the protein is being released from the 
cytoplasm into the solution.  The widths of CI2 crosspeaks were measured over a 
period of 24 h, and no change in peak linewidth was detected.  This observation 
suggested that the increasing peak intensity was due solely to a change in 
concentration.  This change was attributed to an increase in cell density in the 
detector region of the spectrometer.  This was referred to as “cell settling”.   
Cell settling was an inaccurate interpretation of the data.  Figure 3.2 shows 
that CI2 was found in the supernatant at the beginning and the end of the 
experiment.  Since there was also no observable change in linewidths, we conclude 
that the CI2 signal originated from protein in the supernatant and not the cell.  The 
increase in peak intensity was not the result cell settling but protein leaking from the 
cells into the supernatant.  This CI2 result also implies that the CI2 in the cells is not 
observable, although, the concentration inside cells far exceeds the concentration of 
protein in the supernatant (Figure 3.3).  The Almeida lab also concluded an increase 
in peak intensity was the result of increasing the concentration of extracellular 
protein (78).   
 
3.3.2 In-cell NMR and α-synuclein 
Proteins previously used for in-cell NMR were reinvestigated to ensure that 
protein signal was coming from inside the cells, not from the extracellular 
supernatant.  The signal from α-SN for an in-cell experiment is from inside the cells 
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as shown in Figure 3.4.  Figure 3.4 panels A and C show that there is no α-SN 
signal from the supernatant at either the beginning or the end of the experiment. The 
crosspeaks present in panels A and C belong to small molecules that incorporated 
15N during expression.  The spectrum in panel B is identical to the original work of 
McNulty et al. (20).   Also, SDS-PAGE analysis shows no protein detected in the 
extracellular supernatant (Figure 3.5). These data imply that α-SN does not leak 
from the cells during the length of an in-cell NMR experiment.  
 
3.3.3 In-cell NMR and FlgM   
FlgM was also investigated, and it was determined that all signal was from 
inside living E. coli.  Figure 3.6 panels A and C shows that no FlgM is detectable in 
the extracellular supernatant before or after the in-cell NMR experiment.  Panel B 
shows the spectrum of FlgM from the in-cell experiment inside living cells.  The 
spectrum in panel B is identical to the original work of Dedmon et al. (19).  The 
crosspeaks that are present in panel A and C belong to small molecules that 
incorporated 15N during protein expression.  
 
3.3.4 In-cell NMR and apocytochrome b5 
A 15N HSQC spectrum of the supernatant immediately harvested after sample 
preparation is shown in Fig 3.7, panel A; the spectrum from “inside cells” is shown in 
panel B; and the spectrum from the supernatant collected after the in-cell experiment 
is shown in panel C.  Apocytochrome b5 behaves similarly to CI2 for in-cell 
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experiments.  According to SDS-PAGE, the extracellular protein is minimal (Fig. 
3.8); however, the signal is only observed from the extracellular protein (Fig 3.7).  I 
concluded the signal from apocytochrome b5 during in-cell experiments arises from 
the extracellular protein.   
3.3.5 In-cell NMR of encapsulated cells  
Panels A and B in Figure 3.9 show spectra from encapsulated cells 
expressing α-SN and CI2, respectively.  α-SN can be detected inside encapsulated 
cells proving we can still observe protein from inside cells even when encapsulated 
(Fig. 3.9A).  On the other hand, CI2 was not observed inside alginate-encapsulated 
cells (Fig. 3.9B).  CI2, however, was observed after dissolution of the encapsulates 
(Fig. 3.10).  This proves encapsulation prevents protein leakage into the surrounding 
media.  The observation also shows that CI2 cannot be observed in the E. coli 
cytoplasm, suggesting the increased viscosity of the cytoplasm compared to dilute 
solution affects globular proteins differently than natively-disordered proteins.   
 
3.4 Conclusions 
The interpretation of in-cell NMR data must be pursued with caution.  As 
determined above, SDS-PAGE analysis of the extracellular supernatant is not 
sufficient to support the interpretation that the spectra of CI2 and apocytochrome b5 
from “in-cell” experiments comes from protein in the cell.  The protein signals never 
originated from inside cells, although the concentration of protein found in the 
supernatant was minimal. The two papers from our group on in-cell NMR of 
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apocytochrome b5 have been retracted (79).  The definitive control for in-cell NMR is 
to measure the signal in the supernatant at the beginning and end of the experiment.   
 Both apocytochrome b5 and CI2 are ideal candidates for in-cell NMR since 
they are small, soluble, and overexpressed; yet, it appears that no signal arises from 
inside cells.  Recent results measuring protein dynamics show that globular proteins 
are more affected by the intracellular viscosity than natively-disordered proteins (Li, 
et al. in press, JACS).  The increased cytoplasmic viscosity increases the transverse 
relaxation rates of CI2, leading to line-broadening and no observable signal.  The 
encapsulation study supports this reasoning because it proves that CI2 cannot be 
observed inside E. coli.  The data also suggest that natively-disordered proteins are 
better suited for in-cell NMR on cells with high cytoplasmic viscosity such as E. coli 
and yeast.   
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3.5 Figures 
 
 
 
 
 
 
 
     Figure 3.1. Schematic of encapsulation device.
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Figure 3.2. Spectra of chymotrypsin inhibitor 2 from in-cell NMR experiment. 
Panel A:  Spectrum collected on the supernatant from cells expressing CI2. The 
supernatant was collected from immediate centrifugation of Sample 1.  Panel B:  
Spectrum collected on an in-cell sample of CI2 (Sample 2).  Panel C:  Spectrum 
collected on the supernatant collected from the in-cell sample of CI2 (from panel B) 
after 2 h incubation at room temperature under anaerobic conditions.   
A 
B 
C 
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Figure 3.3. Commassie-stained, SDS-PAGE of chymotrypsin inhibitor 2 
from the cytoplasm and the supernatant of an in-cell NMR experiment.   
Lanes: 1, Marker; 2, CI2 recovered from cytoplasm; 3, 2-fold dilution of lane 2; 4, 
4-fold dilution of lane 2; 5, CI2 recovered from supernatant; 6, 1 mM CI2 
standard ; 7, 750 µM CI2 standard; 8, 500 µM CI2 standard; 9, 250 µM CI2 
standard; 10, 100 µM CI2 standard; 11, 50 µM CI2 standard.   
 
 
 
 
 
 
1        2       3       4        5                6        7      8       9     10   11 
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Figure 3.4. Spectra of α-synuclein from an in-cell NMR experiment.  
Panel A:  Spectrum collected on the supernatant collected immediately after 
preparation from cells expressing α-SN (Sample 1).   Panel B:  Spectrum collected 
on an in-cell sample of α-SN (Sample 2).  Panel C:  Spectrum collected on the 
supernatant collected from the in-cell sample of α-synuclein (from Panel B) after 2 
h incubation at room temperature under anaerobic conditions.   
 
A B C 
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Figure 3.5. Commassie-stained, SDS-PAGE of α-synuclein recovered from the 
cytoplasm and supernatant of an in-cell NMR experiment.   
Lanes: 1, Marker; 2, 1 mM CI2 standard; 3, 750 µM CI2 standard; 4, 500 µM CI2 
standard; 5,  250 µM CI2 standard; 6, 100 µM CI2 standard; 7, extraceullar α-SN 
from in-cell NMR sample; 8, cytoplasmic α-SN from in-cell NMR sample; 9, 2-fold 
dilution of lane 8; 10, 4-fold dilution of lane 8.  
 
1     2    3     4     5    6    7    8    9    10 
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Figure 3.6. Spectra of FlgM from an in-cell NMR experiment 
Panel A:  Spectrum collected on the supernatant from cells expressing FlgM. The 
supernatant was collected from immediate centrifugation of the sample (Sample 1).  
Panel B:  Spectrum collected on an in-cell sample of FlgM (Sample 2).  Panel C:  
Spectrum collected on the supernatant collected from an in-cell sample of FlgM 
(from Panel B) after 2 h incubation at room temperature under anaerobic conditions.   
A B C 
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Figure 3.7. Spectra of apocytochrome b5 from in-cell NMR experiment. 
Panel A:  Spectrum collected on the supernatant from cells expressing 
apocytochrome b5. The supernatant was collected from immediate centrifugation of 
the sample (Sample 1).  Panel B:  Spectrum collected on an in-cell sample of apo-b5 
(Sample 2).  Panel C:  Spectrum collected on the supernatant collected from an in-
cell sample of apo-b5 (from Panel B) after 2 h incubation at room temperature under 
anaerobic conditions.   
 
 
 
 
A 
B 
C 
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Figure 3.8. Commassie-stained, SDS-PAGE of apocytochrome b5 recovered 
from the cytoplasm and supernatant of an in-cell experiment.   
Lane 1: Marker, Lane 2: cytoplasmic apocytochrome b5, Lane 3:  apocytochrome b5 
recovered from the extracellular supernatant.   
 
 
   1         2        3 
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Figure 3.9. Spectra from α-synuclein and chymotrypsin inhibitor 2 inside cells, 
supernatant, and encapsulated cells. 
Right panel: α-SN, Left panel: CI2, from alginate encapsulated cells. (Li, et al., in 
press, JACS). 
A B
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 Figure 3.10. 1D 15N -filtered spectrum of chymotrypsin inhibitor 2 after 
 dissolving alginate encapsulate. 
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4 In-cell NMR of Pichia pastoris  
4.1   Introduction 
4.1.1 Pichia pastoris 
The yeast, Pichia pastoris, serves as a eukaryotic expression system capable 
of producing milligram-to-gram quantities of recombinant protein. The system has 
the benefits of E. coli –high expression levels in a simple, inexpensive growth media 
and easy control over parameters such as pH, aeration, and carbon source feed 
rate.  It also has the advantages of a eukaryotic synthesis pathway (e.g., 
posttranslational modifications).  These properties make it an interesting target for 
in-cell NMR studies.   
P. pastoris is one of four strains belonging to the genera of methylotrophic 
yeast (80), so named because they utilize methanol as a carbon source in the 
absence of a repressing carbon source, such as glucose.  The enzyme, alcohol 
oxidase, catalyzes the first step in methanol catabolism and is under the control of 
AOX1 promoter (81-83).  This promoter is found in the expression vector to drive 
transcription of your favorite gene (YFG).  Regulation of the AOX1 promoter involves 
repression/derepression and induction mechanisms (83).  For cells grown in the 
presence of methanol, AOX1 mRNA constitutes ~5% of poly(A)+ RNA; whereas, in 
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the presence of other carbon sources, AOX1 mRNA is undetectable (83).  The 
presence of methanol is necessary to induce transcription from the AOX1 promoter 
(81); the absence of a repressing carbon source alone does not result in 
transcription.   
The P. pastoris expression vectors (Invitrogen) have been designed as E. 
coli/ P. pastoris shuttle vectors, containing an origin of replication for use in E. coli.  
The expression vector contains a 0.9 kb fragment from the AOX1 operon composed 
of a 5’ promoter sequence and an AOX1-derived transcription termination sequence 
(Figures 4.1 and 4.2).   
The  P. pastoris expression vectors exploit the propensity for P. pastoris cells 
to undergo homologous recombination between genomic and artificially introduced 
DNAs.  The vector contains a sequence that is shared by the host genome to 
promote recombination events that result in the integration of the vector into the 
target genome (83).  The recombination creates a genetically stable recombinant 
element that is not expunged by the cell in the absence of antibiotic resistance.  The 
recombination can occur as either a single or double crossover event (Figs. 4.3 and 
4.4).  A single crossover yields genomic DNA with YFG under the control of the 
AOX1 promoter and an intact, functional, AOX1 promoter specifically for methanol 
metabolism (Figure 4.3).  The phenotype of these cells is methanol utilization plus 
(Mut+).  The Mut+ cells grow on methanol at the wild-type rate and require high 
feeding rates of methanol (80).  A double crossover replaces the AOX1 promoter 
involved in methanol metabolism with YFG under the control of another AOX1 
promoter, resulting in cells with the phenotype methanol utilization slow (MutS)  
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(Figure 4.4).  The disrupted AOX1 locus forces the cells to metabolize methanol 
using  the weaker AOX2 gene (84).    
  Selectable markers functional in one or both organisms are present on the 
vector.  In P. pastoris HIS4 is one example of a selectable marker gene.  After 
transformation of the shuttle vector into His- auxotrophic yeast cells and upon 
homologous recombination with the genomic DNA, the HIS4 gene is reformed and 
provides for a selectable marker when the transformants are grown on His- media.    
 
4.1.1 Why yeast? 
Recent results from in-cell NMR experiments suggest that the most promising 
proteins for in cell studies belong to the group of natively-disordered proteins (Li, et 
al., in press, JACS).  Among this group, three proteins, α-SN, FlgM, and tau-40, 
have yielded in-cell information from E. coli (19, 20, 77).  The next logical step was 
to study these proteins in a eukaryotic system.  Proteins purified from E. coli  have 
been microinjected into the cytoplasm of Xenopus laevis oocytes and monitored with 
NMR (25, 85).  These proteins, however, lack the posttranslational modifications that 
occur as part of eukaryotic synthesis pathway.  P. pastoris provides the simplest, 
most inexpensive eukaryotic system for endogenous expression of recombinant 
proteins and monitoring with NMR.   The transition from E. coli to P. pastoris for in-
cell NMR should have occurred with relative ease due to the similarities between 
systems.   
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4.2 Materials and Methods 
4.2.1 Ligation  
Genes for the recombinant proteins chymotrypsin inhibitor 2 (CI2), human α-
SN, and FlgM were cloned into the pAO815 yeast/ E. coli shuttle vector (Figure 4.2).  
The pAO815 plasmid was initially transformed into E. coli DH5α cells and the 
transformants plated on LBamp agar plates.  Five-mL cultures of LB were inoculated 
with single colonies and grown overnight at 37 oC with shaking at 225 rpm.  Plasmid 
DNA (pDNA) was retrieved using a Quiagen mini-prep kit.  The pAO815 plasmid 
was linearized with EcoRI at 37 oC, and the enzyme was heat inactivated by 
incubation at 65 oC for 20 min.  The plasmid was then dephosphorylated with calf-
intestinal phosphatase (CIP) for 1 h at 37 oC.  The mixture was electrophoresed on a 
1% agarose gel with 0.1% ethidium bromide (EtBr) at 100 V.  The digested, 
dephosphorylated plasmid was identified by comparison with undigested plasmid, 
cut out of the gel, and recovered in water using a Quiagen gel extraction kit.  
The genes were PCR-amplified with flanking EcoRI restriction sites.  The 
PCR product was electrophoresed on a 1% agarose gel (0.1 % EtBr, 100 V).  The 
product was identified by size comparison with a 1 kb standard DNA marker (NEB), 
removed from the gel, and recovered in water using a gel extraction kit (Quiagen).  
The product was digested with EcoRI at 37 oC for 1 h and then the enzyme was heat 
inactivated at 65 oC for 20 min. This created sticky ends.   
The ligation reaction mixture consisted of digested plasmid and PCR-
amplified gene product in ratios varying from 1:1 to 1:10, T4 ligase (NEB), ligase  
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buffer, and water.  The ratios were determined by comparing the intensities of bands 
on a UV-illuminated agarose gel.  The ligation reaction was carried out at 16 oC 
overnight.  Four µL of each reaction mixture were transformed into 50 µL of 
competent DH5α cells.  The cells were allowed to recover in 350 µL of SOC media 
for 1 h.  Two hundred µL were plated on LBamp agar plates.  Five-mL cultures of 
LBamp were inoculated with individual colonies and grown overnight at 37 oC with 
shaking at 225 rpm.  Plasmid DNA was extracted from the overnight cultures by 
using a miniprep kit (Quiagen), and small aliquots of pDNA were subsequently 
digested with EcoRI at 37oC for 1 h and ran on a 1% agarose gel (0.1% EtBr, 100 
V).  The plasmids containing inserts were identified by size comparison with a 1 kb 
standard DNA marker (NEB) and the sequence of the insert was confirmed by DNA 
sequencing (Genome Analysis Facility, UNC).              
     
4.2.2 Preparation of DNA for transformation into P. pastoris  
The following protocol was used to prepare the pAO815 vector containing 
αSN, CI2, or FlgM for transformation.  The recombinant pAO815 vector was 
linearized in the presence of Sal I (NEB) for 1 h at 37 oC.  The digested plasmid was 
analyzed by agarose gel electrophoresis (1% agarose, 0.1% EtBr, 100 V) to check 
for complete digestion.  The digested DNA was extracted by adding equal parts of a 
phenol: chloroform: isoamyl alcohol mixture (25:24:1), vortexing, and centrifuging at 
12000 x g for 20 min.  The top layer was recovered.  The process was repeated, and 
the two extracts combined.  The DNA was ethanol precipitated by adding 2 volumes 
of 100% ethanol and mixing.  The mixture was centrifuged at 12000 x g for 10 min at 
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4 oC.  The supernatant was discarded, and the pellet was washed with 1 volume of 
70% ethanol and centrifuged at 12000 x g for 2 min.  The supernatant was 
discarded.  The DNA pellet was resuspended in 10 µL of TE buffer, and the 
concentration determined by measuring absorbance at 260 nm.   
 
4.2.3 Spheroplasting 
To enable yeast to incorporate DNA, it is necessary to partially remove the 
cell wall.  The enzyme zymolyase partially digests the cell wall by hydrolyzing its β-1, 
3 glucose polymers.  
Cells were prepared for spheroplasting by streaking the GS115 strain of P. 
pastoris onto a yeast extract, peptone, dextrose (YPD) agar plate to isolate single 
colonies.  The plate was incubated at 30 oC for 2 days.  Ten mL of YPD media in a 
50-mL culture tube was inoculated with a single colony and grown overnight at 30 oC 
with shaking at 250 rpm.  Two-hundred mL of YPD media was placed in three 500-
mL baffled culture flasks, inoculated with 5, 10, and 20 µL of the overnight culture, 
and incubated at 30 oC overnight with shaking at 250 rpm.  After checking the optical 
density at 600 nm (1-cm cuvette), cells were harvested by centrifugation (1500 x g, 
10 min, room temperature;R-T) from a culture with an OD600 between 0.2 and 0.3.  
The supernatant was discarded, and the cell pellet used for spheroplasting.   
The cell pellet was resuspended in 20 mL of sterile water and transferred to a 
50-mL conical tube.  The suspension was centrifuged at 1500 x g for 5 min at R-T, 
and the supernatant was discarded.  The cell pellet was further washed with 20 mL 
of fresh SED [1M sorbitol, 25 mM EDTA, 1M DTT, pH 8.0] and again centrifuged at 
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1500 x g for 5 min.   The cells were then washed with 20 mL of 1 M sorbitol and 
centrifuged as previously described.   The pellet was resuspended in 20 mL of SCE 
buffer [1M sorbitol, 1 mM EDTA, 10 mM sodium citrate, pH 5.8], and the suspension 
was divided between two 50-mL conical tubes.  One tube was used to determine the 
optimal time of digestion with zymolyase to make spheroplasts.   
Digestion of the cell wall was initiated by adding 7.5 µL (11 units) of enzyme 
to one conical tube of cells and incubating at 30 oC.  Two-hundred µL aliquots of the 
digestion mixture were quenched with 800 µL of a 5% (w/v) SDS solution at two 
minute intervals for 40 min.  Absorbance was monitored at 800 nm (1-cm 
pathlength) for each sample and used to determine the percent spheroplasting from 
the following equation:                               
% Spheroplasting = 100 – [(OD800 at time t / OD800 at time 0) x 100]   
An optimal incubation period results in approximately 70% spheroplasting.  After the 
optimal incubation period was determined (~20 min), 7.5 µL of zymolyase was 
added to the second conical of cells and incubated at 30 oC for the predetermined 
time period.  The cells were harvested at 750 x g for 10 min at R-T, washed with 10 
mL of CaS buffer [1 M sorbitol, 10 mM Tris-HCl, pH 7.5, 10 mM CaCl2], harvested 
once more, and then resuspended in 0.6 mL of CaS buffer.  Samples were used 
within 30 min.    
 
4.2.4 Transformation of P. pastoris  
Each transformation reaction comprised 100 µL of spheroplast mixture and 10 
µg of linearized DNA.  After 10 min of incubation at R-T, 1.0 mL of fresh PEG/ CaT 
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[40% PEG 3350 (w/v); 20 mM Tris-HCl, pH 7.5, 20 mM CaCl2] solution was added to 
the cells.  The sample was mixed gently and incubated again for 10 min at R-T.  The 
cells were harvested (750 x g, 10 min, R-T), and the excess PEG/ CaT solution was 
carefully removed.  The pellet was resuspended in 150 µL of SOS media 
(Invitrogen), incubated at R-T for 20 min.  Sorbitol (850 µL of 1 M solution) was then 
added.    
Between 100- and 300- µL of the spheroplast-DNA mixture was added to 10 
mL of molten regeneration dextrose media [RD; 1 M sorbitol, 2% dextrose, 1.3% 
YNB, 4 x 10-5% biotin, 0.005% amino acids] and poured onto RD agar plates.  After 
the top agar hardened, the plates were inverted and incubated at 30 oC for 4 to 6 
days.   
 
4.2.5 Test expression of recombinant proteins  
A successful transformation results in the reformation of HIS4 and colony 
growth on his- plates.  The colonies produced are His+ transformants that are either 
methanol utilization plus (Mut+) or methanol utilization slow (MutS). Transformants 
resulting from a Sal I digest and transformation into GS115 should be Mut+; 
however, there is a chance that recombination will disrupt the wild-type AOX1 gene 
(Fig. 4.4) and create a His+ MutS transformant.  The transformants, therefore, were 
screened to determine the phenotype.  
Transformants were streaked onto minimal dextrose, [MD, 1.3% (w/v) yeast 
nitrogen base (YNB), 4 x 10-5% (w/v) biotin, 2% (w/v) dextrose], and minimal 
methanol [MM, 1.3% (w/v) YNB, 4 x 10-5 % (w/v) biotin, 0.5% (w/v) methanol] agar 
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plates to isolate single colonies.  The plates were incubated at 30 oC for 2 days.  A 
His+ Mut+ phenotype results in faster growth on MM plates, resulting in larger 
colonies on MM plates compared to MD plates.  A His+ MutS phenotype results in 
slower growth in the presence of methanol as manifested by smaller colonies on MM 
plates compared to MD plates.  His+ Mut+ transformants were selected for test 
expression.    
Recombination can occur in different ways that affects protein expression.  It 
is necessary, therefore, to screen many transformants.  Instead of conducting a test 
expression in liquid media on 10-20 colonies which would take approximately 10 
days for growth and test expression, we developed a high-throughput screening 
method which is done in two days.  The His+ Mut+ transformants were screened for 
protein expression by SDS-PAGE analysis on colonies from the MM plates.   
The colonies were scraped off the plates with and resuspended in 30 µL of 
breaking buffer [50 mM sodium phosphate, pH 7.4, 1 mM phenylmethylsulfonyl 
fluoride (PMSF), 1 mM EDTA, and 5% (w/v) glycerol].  An equal volume of 0.5 mm 
acid-washed glass beads was added, and the samples were subjected to 8 cycles of 
30 sec vortexing followed by 30 sec incubating on ice.  The samples were then 
centrifuged at 12000 x g for 10 min at 4 oC.  The supernatant was collected, mixed 
with 30 µL of 2X SDS-PAGE loading buffer [100 mM Tris-HCl, pH 6.8, 4% (w/v) 
SDS, 0.2% (w/v) bromophenol blue, 20% (w/v) glycerol, 200 mM DTT], and boiled 
for 10 min.  Fifteen µL were loaded into an 18% gel (Biorad) and electrphoresed for 
50 min at 200 V.  The gel was Coomassie-stained and then destained.  α-SN gels 
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were also subjected to Western blot analysis.  Plates with colonies producing the 
respective protein were saved for test expressions in liquid media.    
The MD plate corresponding to the MM plate containing protein-expressing 
colonies was identified.  A single colony from the MD plate was used to inoculate 25 
mL of buffered glycerol-complex media [BMGY; 1% (w/v) yeast extract, 2% (w/v) 
peptone, 100 mM potassium phosphate, pH 6.0, 1.3% (w/v) YNB, 4 x 10-5% (w/v) 
biotin, 1% (w/v) glycerol] in a 250 mL baffled flask.  This culture was grown for 16-18 
h at 30 oC with shaking at 250 rpm.  The cells were harvested in log phase (OD600 2-
6) by centrifugation at 1500 x g for 5 min at R-T.  The pellet was resuspended in a 
buffered methanol-complex media [BMMY, 1% (w/v) yeast extract, 2% (w/v) 
peptone, 100 mM potassium phosphate, pH 6.0, 1.3% (w/v) YNB, 4 x 10-5% (w/v) 
biotin, 0.5% (w/v) methanol] to an OD600 of 1.0.  This solution was placed in a 1-L 
baffled flask, covered with two layers of cheesecloth, and returned to the incubator 
(250 rpm, 30 oC).  Methanol was added to a final concentration of 0.5% twice a day.  
One mL aliquots were taken at 0, 6, 12, 24, 36, 48, 60, 72, 84, and 96 h.  The 
aliquots were centrifuged at 12000 x g for 5 min at R-T.  The supernatant was 
separated from the cell pellet, and both were kept for SDS-PAGE analysis.       
For SDS-PAGE analysis, the cell pellets were thawed on ice and 
resuspended in 100 µL of breaking buffer.  An equal volume of acid-washed glass 
beads was added to the solution.  The solution was then subjected to 8 cycles of 30 
sec vortexing followed by a 30 sec incubation on ice.  The sample was centrifuged at 
12000 x g for 10 min, and the clear cell lysate and pellet were separated.  Fifty mL of 
2X SDS-PAGE loading buffer was added to the clear cell lysate.  Also, 50 µL of 2X 
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SDS loading buffer was added to 50 µL of the cellular supernatant from each time 
point to test for protein secretion.  The samples were boiled for 10 min, and 15 µL 
from each sample was loaded onto an 18% polyacrylamide SDS gel and 
electrophoresed for 50 min at 200 V.  The gel was Coomassie-stained and 
destained.  Gels for α-SN were also subjected to Western blot analysis (Invitrogen 
primary antibody, Pierce secondary antibody).  
  
4.3 Results 
4.3.1 Expression and in-cell NMR of CI2 
Expression of CI2 in P. pastoris was tested in two different media, buffered 
methanol-complex media (BMMY) and unenriched Yeastone® media. (Spectra 
Stable Isotopes).  The complementary enriched Yeastone® media was used for in-
cell NMR experiments with P. pastoris. Detectable levels of expression in BMMY 
media appeared after 16 h on a Coomassie-stained gel (Fig. 4.5).  Similar results 
were obtained for expression in the Yeastone® media (Fig. 4.6).   
Favorable expression levels in unenriched Yeastone® prompted in-cell NMR 
experiments.  P. pastoris cells expressing 15N-enriched CI2 were harvested after 24 
h and resuspended in unenriched Yeastone®.  An 15N HSQC spectrum was collected 
on these cells for 16 h (Fig. 4.7).  The resulting spectrum was of background 
molecules.  CI2 was not detected inside cells by NMR but was observed on a 
Coomassie-stained SDS gel (Fig. 4.8).   
 
71 
4.3.2 Expression and in-cell NMR of α-SN 
The initial test expression was conducted without screening for colonies 
producing α-SN on MM plates.  The test expression in BMMY media resulted in no 
detectable level of expression on a Coomassie-stained SDS gel (Fig. 4.9) or a 
Western blot with an anti-synuclein antibody (Invitrogen) (data not shown).   Next, 
we screened colonies grown on minimal methanol (MM) agar plates for the presence 
of α-SN and observed protein production in 2 out of 15 colonies (Fig. 4.10).   
A test expression with these colonies in BMMY and Yeastone® was 
unsuccessful.  Western blot analysis showed no detectable level of expression (Fig. 
4.11) from the clear cell lysate.  α-SN, however, was found in the insoluble cell 
lysate.  Insoluble α-SN accumulated after 48 h of expressing in both Yeastone and 
BMMY media (Fig. 4.12 and Fig. 4.13) leading us to limit further experiments to less 
than 48 h.   
An in-cell NMR experiment was conducted on P. pastoris cells expressing 
15N-enriched α-SN.  A 16 h 15N HSQC spectrum from cells expressing for 24 h 
resulted in signal from only background molecules (Fig. 4.14).  A Coomassie-stained 
SDS gel (Fig. 4.15) and a Western blot (figure not shown) of lysed cells revealed 
that α-SN was present in the soluble and insoluble fractions.     
 
4.3.3 Expression of FlgM 
The initial test expression of FlgM in BMMY media resulted in no 
distinguishable band on a Coomassie-stained SDS gel (Fig. 4.16).  Since anti-FlgM 
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antibody is not available, Western blot analysis could not be done.  To determine if 
FlgM was expressed, we inserted a 6x histidine tag, for which an antibody is 
available, transformed, and tested for expression.   
After successful mutagenesis and transformation reactions, colonies grown 
on MM agar plates were tested for presence of FlgM.  The initial screen revealed 
one colony producing His-FlgM (Fig. 4.17).  The test expression in BMMY and 
Yeastone media, however, showed no detectable level of His-FlgM (Fig. 4.18).  A 
secondary screen for His-FlgM, along with α-SN and CI2, resulted in no colonies 
producing His-FlgM, including the initial colony (Fig. 4.19).  CI2 was detected in a 
colony grown on an MM agar plate, thereby validating the method (Fig. 4.19).  
Further progress in expressing His-FlgM in P. pastoris is needed before proceeding 
with in-cell NMR experiments.   
 
4.4 Conclusions 
The high viscosity of the cytoplasm is a deterrent to measuring proteins inside 
living cells by NMR.  We were unable to observe the globular protein CI2 inside E. 
coli, where the viscosity at least 9 times greater than that of water (16).  The 
cytoplasmic viscosity of yeast cells is greater than that of E. coli (86-88); therefore, 
the lack of observable CI2 inside P. pastoris was not unexpected.       
Recent results suggest that natively-disordered proteins are the most 
promising for in-cell NMR in eukaryotic cells (Li, et al., in press, JACS).  The flexible 
backbone of disordered proteins is affected less by the increased viscosity of the 
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cytoplasm than a globular protein.  Within this group, we have observed FlgM, α-SN, 
and tau inside living E. coli but did not detect α-SN inside P. pastoris.   
Another necessary component for observing proteins inside cells by NMR is 
high level of expression.  α-SN, however, forms cytoplasmic inclusion bodies in a 
concentration-dependent manner in  Saccharomyces cervasiae (89) and associates 
with the plasma membrane (89).  These findings are in agreement with our 
observations of α-SN separating into the insoluble fraction.  In both instances, α-SN 
would behave like a larger, globular protein and be affected by the increased 
viscosity of the yeast cytoplasm making it difficult, if not impossible, to observe 
inside P. pastoris.  
The P. pastoris system promotes high expression levels along with 
posttranslational modifications, making it an interesting target for in-cell NMR.  The 
main advantage of the system is a significant disadvantage for in-cell NMR.  Instead 
of significantly increasing protein concentration per cell, however, P. pastoris yields 
gram quantities of protein by increasing cell density (90, 91).  Not only is it then 
difficult to observe the protein of interest over the background molecules but also the 
spectral quality deteriorates with increasing cell density in the NMR tube (16).   
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4.5 Figures  
 
 
 
 
Figure 4.1. General diagram of P. pastoris vector 
  “YFG” is your favorite gene (83).  The stars enclose the 
recombination sequence.  
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                   Figure 4.2. Yeast plasmid map used in present studies 
  (Invitrogen) 
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Figure 4.3. Single crossover during a homologous recombination event with 
HIS4 selectable marker 
(Invitrogen) 
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Figure 4.4. Double crossover event during homologous recombination 
A double crossover event between the AOX1 promoter and 3’ AOX1 regions of 
the vector and genomic DNA results in the complete removal of the AOX1 coding 
region.  The resulting phenotype is His+MutS.  (Invitrogen) 
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 Figure 4.5. Coomassie-stained gel of test expression for 
chymotrypsin inhibitor 2 in P. pastoris 
Representative SDS-PAGE gel of a test expression for CI2 in P. 
pastoris in BMMY media. Lanes: 1, 755 Marker; 2, CI2 standard; 
3, Test expression 1, 9 h; 4, Test expression 1, 16 h; 5, Test 
expression 1, 24 h; 6, Test expression 1, 40 h; 7, Test expression 
1,  48 h; 8, Test expression 1, 72 h; 9, Test expression 1, 96 h; 
10, Test expression 2, 9 h; 11, Test expression 2, 16 h; 12, Test 
expression 2, 24 h; 13, Test expression 2, 40 h; 14, Test 
expression 2, 48 h; 15, Test expression 2, 72 h; 16, Test 
expression 2, 96 h.  Test expression 1 and 2 indicate two different 
colonies.  
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
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Figure 4.6. Coomassie-stained SDS gel of chymotrypsin 
inhibitor 2 test expression in P. pastoris in Yeastone 
media 
Lanes: 1, Marker; 2, CI2 standard; 3, 0 h; 4, 6 h 5, 12 h; 6, 24 
h; 7, 36 h; 8, 48 h; 9, 60 h; 10, 72 h; 11, 96 h.  
 
1 2 3 4 5 6 7 8 9 10 11
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Figure 4.7. NMR spectrum P. pastoris cells expressing chymotrypsin inhibitor 2
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Figure 4.8. Coomassie-stained SDS gel of chymotrypsin inhibitor 2 after in-cell 
NMR experiment 
Lanes: 1, 755 Marker; 2, clear cell lysate; 3, insoluble material
1                             2              3 
82 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9. Coomassie-stained SDS gel for test expression of 
α-synuclein in P. pastoris in BMMY media 
Lanes: 1, 755 Marker; 2, α-SN standard; 3, Test expression 1, 9 
h; 4, Test expression  1, 16 h; 5, Test expression 1, 24 h; 6, Test 
expression 1, 40 h; 7, Test expression 1, 48 h; 8, Test expression 
1, 72 h; 9, Test expression 1, 96 h; 10, Test expression 2, 9 h; 11, 
Test expression 2, 16 h; 12, Test expression 2, 24 h; 13, Test 
expression 2, 40 h; 14, Test expression 2, 48 h; 15, Test 
expression 2, 72 h; 16, Test expression 2, 96 h.  Test expression 
1 and 2 indicate two different colonies. 
 
1    2    3     4     5    6     7    8    9    10   11  12   13  14  15   16    
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Figure 4.10. Representative Western blot 
analysis for presence of α-synuclein from 
screening colonies grown on MM agar plates. 
Lanes: 1, α-SN standard; 2, colony 1; 3, colony 2; 
4, colony 3; 5, colony 4 .  The arrow indicates 
monomeric α-synuclein.   
 
1           2           3            4             5 
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Figure 4.11. Western blot analysis of α-synuclein test 
expression in BMMY and Yeastone medias. 
Lanes: 1, α-SN standard; 2, BMMY media, 6 h; 3, BMMY media, 
12 h; 4, BMMY media, 24 h; 5, BMMY media, 36 h; 6, BMMY 
media, 48 h; 7, BMMY media, 72 h; 8, α-SN standard; 9, Yeastone 
media, 6 h; 10, Yeastone media, 12 h; 11, Yeastone media, 24 h; 
12, Yeastone media, 36 h; 13, Yeastone media, 48 h; 14, Yeastone 
media 72 h 
   1      2     3     4     5     6     7       8      9    10   11   12   13  14   
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Figure 4.12. Coomassie-stained SDS gel of α-synuclein 
insoluble material from test expression with P. 
pastoris. 
Lanes: 1, Marker; 2, -SN standard; 3, Test expression 1, 
BMMY media, 24 h; 4, Test expression 1, BMMY media, 
48 h; 5, Test expression 1, BMMY media, 72 h; 6, Test 
expression 2, BMMY media, 24 h; 7, Test expression 2, 
BMMY media, 48 h; 8, Test expression 2, BMMY media, 
72 h; 9, Test expression 1, Yeastone, 24 h; 10, Test 
expression 1, Yeastone, 48 h; 11, Test expression 1, 
Yeastone, 72 h; 12, Test expression 2, Yeastone, 24 h; 13, 
Test expression 2, Yeastone, 48 h; 14, Test expression 2, 
Yeastone, 72 h.  Test expression 1 and 2 indicate two 
different colonies. 
1     2     3     4    5    6    7    8    9    10   11  12  13   14  
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Figure 4.13. Representative gel of Western blot 
analysis of insoluble α-synuclein from test 
expression in BMMY and Yeastone. 
Lanes: 1, α-SN standard; 2, Test expression 1, Yeastone media, 
24 h; 3, Test expression 1, Yeastone media, 48 h; 4, Test 
expression 1, Yeastone media, 72 h 
 
 
        1             2                            3           4 
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      Figure 4.14. NMR spectrum of in-cell experiment for α-synuclein 
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Figure 4.15. Western blot of α-synuclein samples after an in-
cell NMR experiment with P. pastoris. 
Lanes: 1, clear cell lysate; 2, insoluble material  
 
  1        2 
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Figure 4.16. Coomassie-stained SDS gel of 
His-FlgM test expression in P. pastoris in 
BMMY media. 
Lanes: 1, Marker; 2, 6 h; 3, 12 h; 4, 24h, 5, 36 h; 6, 48 h, 
7, 72 h.  The arrow dictates the probable location of FlgM.  
 
1     2    3    4     5     6    7   
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Figure 4.17. Coomassie-stained SDS-PAGE analysis for presence of His-FlgM 
after screening colonies grown on MM agar plates. 
Lanes: 1, FlgM standard; 2, colony 1; 3, colony 2; 4, colony 3; 5, colony 4; 6, colony 
5; 7, colony 6; 8, colony 7; 9, colony 8; 10, colony 9; 11, colony 10; 12, colony 11; 
13, colony 12; 14, colony 13; 15, colony 14; 16, colony 15; 17, colony 16  
  
  1    2     3    4    5     6    7    8    9    10   11  12   13   14  15  16  17   
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Figure 4.18. Coomassie-stained SDS gel of His-FlgM from test 
expression of P. pastoris in BMMY and Yeastone media. 
Lanes: 1, Marker; 2, FlgM standard; 3, BMMY media, 6h; 4, BMMY 
media, 12h; 5, BMMY media, 24 h; 6, BMMY media, 36 h; 7, BMMY 
media, 48 h; 8, BMMY media, 72 h; 9, BMMY media, 96 h; 10, 
Yeastone media, 6h; 11, Yeastone media, 12h; 12, Yeastone media, 
24 h; 13, Yeastone media, 36 h; 14, Yeastone media, 48 h; 15, 
Yeastone media 72 h 
 
 
1     2    3     4    5    6     7    8     9   10   11   12   13  14   15   
92 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.19. Coomassie-stained SDS-PAGE analysis 
for screening the presence of His-FlgM, α-synculein, 
or chymotrypsin inhibitor 2 in P. pastoris colonies 
grown on MM plates. 
Lanes: 1, 756 Marker 1; 2, 755 Marker; 3, colony 1; 
4, colony 2; 5, colony 3; 6, colony 4; 7, 755 Marker; 8, 
756 Marker; 9, α-SN, 10, CI2 
 
1    2    3     4      5     6    7    8      9    10 
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